{{medical}}
{{Infobox_Disease |
  Name           = 家族性澱粉樣物多發性神經病變 |
  Image          = |
  Caption        = |
  DiseasesDB     =  |
  ICD10          =  |
  ICD9           =  |
  ICDO           = |
  OMIM           = 105210 |
  MedlinePlus    = |
  eMedicineSubj  = |
  eMedicineTopic = |
  MeshID         = |
}}

'''家族性澱粉樣物多發性神經病變'''（英文：'''Familial amyloid polyneuropathy'''，簡稱'''FAP'''）是一種[[染色體|染色體]][[顯性遺傳|顯性]][[遺傳病|遺傳病]]，是致命且無法根治的[[神經病變|神經病變]]，由[[葡萄牙|葡萄牙]][[神經學家|神經學家]]Corino da Costa Andrade於1952年首先發現。患者[[肝臟|肝臟]]缺乏一種分解[[澱粉樣蛋白|澱粉樣蛋白]]的[[酶|酶]]，導致澱粉樣蛋白不正常地累積，影響[[神經系統|神經系統]]、[[心臟|心臟]]及其他[[器官|器官]]的功能，通常在40歲前會因心臟衰竭而死亡。

== 參考資料 ==
{{refbegin}}
* [http://hk.news.yahoo.com/article/100821/4/jte3.html 罕見遺傳病 毒素積聚致死 家族性澱粉樣物多發性神經病變]，《明報》，2010年8月22日
{{refend}}

==外部連結==
* [http://apollotrial.com/ World wide clinical trial for the evaluation of an investigational medicine for the possible treatment of Familial Amyloidotic Polyneuropathy (FAP)]
* [http://ttrstudy.com/ Study for Familial Amyloid Polyneuropathy FAP]
* [http://www.ncbi.nlm.nih.gov/books/NBK1194/  GeneReviews/NIH/NCBI/UW entry on Familial Transthyretin Amyloidosis]
* [http://stanfordhospital.org/clinicsmedServices/COE/heart/DiseasesConditions/amyloid/ Stanford University Amyloid Center]
* {{cite journal |author=Sousa MM, Du Yan S, Fernandes R, Guimaraes A, Stern D, Saraiva MJ |title=Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways |journal=J. Neurosci. |volume=21 |issue=19 |pages=7576–86 |date=October 2001 |pmid=11567048 |url=http://www.jneurosci.org/cgi/pmidlookup?view=long&pmid=11567048}}
* [http://www.paramiloidose.com Portuguese Paramyloidosis Association (in Portuguese)]
* [http://www.paramiloidose.org/ Center for study and support for Paramyloidosis (in Portuguese)]

{{Amyloidosis}}
{{medical-stub}}

[[Category:神經系統疾病|Category:神經系統疾病]]
[[Category:遺傳病|Category:遺傳病]]
[[Category:代謝疾病|Category:代謝疾病]]